3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
9
Cholangiocarcinoma
8
Pancreatic Neoplasms
7
Gallbladder Neoplasms
6
Ovarian Neoplasms
4
Esophageal Neoplasms
4
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Sarcoma
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Liver Neoplasms
2
Klatskin Tumor
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Uterine Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdomyosarcoma
1
Resectable Intrahepatic Cholangiocarcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
PRETEXT I Hepatoblastoma
1
Mesothelioma, Malignant
1
Liposarcoma
1
Hepatoblastoma
1
Gastrointestinal Neoplasms
1
Gastric Adenocarcinoma
1
Fibrolamellar hepatocellular carcinoma
1
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Melphalan
4
fludarabine
3
Granulocyte Colony-Stimulating Factor
3
Cyclophosphamide
3
Busulfan
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Vemurafenib
2
Trabectedin
2
Thiotepa
2
Temozolomide
2
Sirolimus
2
Mesna
2
LY3023414
2
Cytoreduction Surgical Procedures
2
Cisplatin
2
talazoparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Platinum
×
Gastrointestinal
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled